Wound Healing Disorders
📧 Sign up to get email alerts when something new happens for Wound Healing Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-03-14Clinical Trial Update: Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design" [Phase 3]
A Phase 3 clinical trial evaluating hyaluronic acid with perfluorodecalin and Physalis angulata extract for wound healing after split-thickn…
-
EMA withdrawal · 2012-08-15EMA Withdrawn: Regranex (becaplermin) — Janssen-Cilag International NV
The EMA withdrew Regranex (becaplermin) from the market for wound healing and skin ulcers at Janssen-Cilag International NV on 11/10/2010.